Last updated on June 2019

Administration of Kisspeptin in Patients With Hyperprolactinemia


Brief description of study

The goal of this project is to explore the use of exogenous pulsatile kisspeptin as a therapeutic alternative for patients with hyperprolactinemia who are intolerant to current therapies.

Funding Source - FDA OOPD

Clinical Study Identifier: NCT02956447

Find a site near you

Start Over